This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Philipp Hadwiger
Vice President, Head of R&D at Axolabs
Speaker

Profile

After earning his doctoral degree from the Technical University of Graz, Austria, Philipp started his industry career in 2000 at Ribopharma AG and held positions of increasing responsibility at Alnylam Europe AG. After Roche’s acquisition of Alnylam’s European site, Philipp served as Director of Chemistry at Roche’s Centre of Excellence for RNA Therapeutics and was promoted to Senior Director of Chemistry at Axolabs where he currently serves as Managing Director. Philipp has published 40 peer-reviewed articles and is a named inventor on more than 20 patents.

Agenda Sessions

  • Chromatographic Tools for the Bioanalysis of Oligonucleotide Therapeutics

    12:05pm